Advertisement Much has been published recently about the Public Readiness and Emergency Preparedness Act (“PREP Act” or “Act”) in the COVID-19 era.[1] Its protections, including broad immunity from liability, have been extended to individuals and companies involved in the design, manufacture, distribution and administration of “countermeasures” against the SARS-CoV-2 virus. Although the PREP Act has been … Continue reading PREP Act Immunity and Its Application in Shareholder Derivative Litigation: A Modest Proposal